Leaddisc · Newsroom
LDC and HZI enter partnership for the discovery of new drugs against multi-resistant bacteria
The Lead Discovery Center GmbH (LDC) and the Helmholtz Centre for Infection Research (HZI) will be working in close cooperation to identify and optimize new drug candidates against methicillin-resistant Staphylococcus aureus (MRSA).April 1, 2015
LDC Receives 1 Million Euros from the Max Planck Foundation
The Lead Discovery Center receives one million euros from the Max Planck Foundation for the development of new drug candidates.March 10, 2015